Wednesday, June 10, 2026

pharma Β· No medical condition. Β· Generalized Myasthenia Gravis

Anaxis Pharma

Anaxis Pharma clinical programs β€” 642 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Melbourne, AU HQ
2017 Founded
7 Employees
TGA registrant Type
Company details
Status
Public
HQ
Melbourne, AU
Founded
2017
Employees
7
Programs
642
Drugs
673
Patents
0
Intelligence Β· Clinical Programs

Anaxis Pharma projects

642 ClinicalTrials.gov programs sponsored by Anaxis Pharma.

Anaxis Pharma has 642 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 14 of 14
  1. VPH-GXL-2025-1

    Lacuna Pharma Pty Ltd

    Hypolactasia

    phase 1 other active

    1 trial
  2. 844700336/0156/1

    Lacuna Pharma Pty Ltd

    Erectile dysfunction

    approved small molecule active

    1 trial
  3. AGAMREE 40 mg/ml oral suspension

    Lacuna Pharma Pty Ltd

    Duchenne Muscular Dystrophy

    approved small molecule active

    1 trial
  4. BCX7353-312

    Lacuna Pharma Pty Ltd

    Hereditary Angioedema

    approved small molecule active

    1 trial
  5. BV-2020/08

    Lacuna Pharma Pty Ltd

    Respiratory Tract Infections with Wheezing Lower Respiratory Illness

    approved small molecule active

    1 trial
  6. Epidyolex 100 mg/ml oral solution

    Lacuna Pharma Pty Ltd

    Tuberous Scerlosis Complex

    approved small molecule active

    1 trial
  7. Feraccru 30 mg hard capsules

    Lacuna Pharma Pty Ltd

    iron deficient

    approved small molecule active

    1 trial
  8. LacTEST 0,45 g polvo para soluciΓ³n oral.

    Lacuna Pharma Pty Ltd

    Lactose intolerance

    approved small molecule active

    1 trial
  9. Livmarli 9.5 mg/mL oral solution

    Lacuna Pharma Pty Ltd

    Progressive Familial Intrahepatic Cholestasis, Alagille syndrome

    approved small molecule active

    1 trial
  10. PLACEBO, ISMIGEN tabletki podjezykowe

    Lacuna Pharma Pty Ltd

    Respiratory Tract Infections

    approved small molecule active

    1 trial
  11. Pariglasgene brecaparvovec

    Lacuna Pharma Pty Ltd

    Glycogen storage disease type Ia (GSDIa)

    approved small molecule active

    1 trial
  12. R668-AS-2373

    Lacuna Pharma Pty Ltd

    Asthma

    approved small molecule active

    1 trial
  13. RES-6128-C1

    Lacuna Pharma Pty Ltd

    Severe vitamin D deficiency

    approved small molecule active

    1 trial
  14. Tantum Verde P 3 mg pastiglie gusto menta

    Lacuna Pharma Pty Ltd

    NON STREPTOCOCCAL PHARYNGOTONSILLITIS

    approved small molecule active

    1 trial
  15. UNI-BETAIN

    Lacuna Pharma Pty Ltd

    Functional Dyspepsia

    approved small molecule active

    1 trial
  16. Wegovy FlexTouch solution for injection in pr... for Adipositas

    Lacuna Pharma Pty Ltd

    Adipositas

    approved small molecule active

    1 trial
  17. Yuflyma solution for injection in pre-filled pen for Rheumatoid arthritis

    Lacuna Pharma Pty Ltd

    Rheumatoid arthritis

    approved small molecule active

    1 trial
  18. bimekizumab

    Lacuna Pharma Pty Ltd

    Moderate to Severe Plaque Psoriasis, Psoriatic arthritis

    approved small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Anaxis Pharma have?

642 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.